Results 51 to 60 of about 499,895 (395)

The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy [PDF]

Кардіохірургія та інтервенційна кардіологія, 2020
Hypertrophic obstructive cardiomyopathy іs a relatively common condition and one of the most common causes of sudden cardiac death in young age. One of the options for the surgical treatment of this pathology is septal myoectomy, which has been the gold ...
B.M. Todurov, G.I. Kovtun, A.V. Khokhlov, O.V. Pantazi, A.O. Shpachuk, A.Yu. Melnik, A.O. Maksakov, A.S. Batsiun   +7 more
doaj   +1 more source

A simple prognostic index in acute heart failure [PDF]

, 2018
Background Rapid effective triage is integral to emergency care in patients hospitalized for heart failure, to guide the type and intensity of therapy.
Cristina MOLLICA, Lanfranco ANTONINI, Nadia ASPROMONTE, Vincenzo PASCERI   +3 more
core   +1 more source

Effect of beta‐blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy

European Journal of Heart Failure, 2022
In the EXPLORER‐HCM trial, mavacamten improved exercise capacity and symptoms in patients with obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten effects on the primary endpoint, a composite of peak oxygen consumption (VO2) and New York Heart ...
M. Wheeler, D. Jacoby, P. Elliott, S. Saberi, Sheila M. Hegde, N. Lakdawala, J. Myers, A. Sehnert, J. Edelberg, Wanying Li, I. Olivotto   +10 more
semanticscholar   +1 more source

Symptomatic Obstructive Hypertrophic Cardiomyopathy [PDF]

Circulation: Cardiovascular Interventions, 2013
Hypertrophic cardiomyopathy (HCM) is a common, yet challenging condition for clinical management. The majority of these patients have evidence of left ventricular outflow tract (LVOT) obstruction that may be asymptomatic or associated with debilitating symptoms of heart failure.
Paul Sorajja, Rick A. Nishimura, Steve R. Ommen   +2 more
openaire   +3 more sources

DYNAMICS OF CARDIOVASCULAR SYSTEM PARAMETERS ON A BACKGROUND OF APPLICATION OF ADRENERGIC BLOCKERS IN CHILDREN WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Педиатрическая фармакология, 2007
The article is dedicated to the issue of curing children with obstructive form of hypertrophic cardiomyopathy. It presents a complex evaluation of adrenergic blockers influence on the clinical finding, heart rate disorder and vegetative regulation of ...
E.A. Tikhomirova, O.O. Kupriyanova, E.N. Basargina, A.P. Ivanov   +3 more
doaj   +2 more sources

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance. [PDF]

, 2015
BackgroundsPrevious studies have shown that diffusion-weighted cardiovascular magnetic resonance (DW-CMR) is highly sensitive to replacement fibrosis of chronic myocardial infarction. Despite this sensitivity to myocardial infarction, DW-CMR has not been
Bi, Xiaoming, Fan, Zhaoyang, Kellman, Peter, Li, Debiao, Lu, Minjie, Nguyen, Christopher, Zhao, Shihua   +6 more
core   +2 more sources

Quantitative and Qualitative Analysis on Sex and Gender in Preparatory Material for National Medical Examination in Germany and the United States [PDF]

, 2020
Background: Sex- and gender-based medicine (SGBM) should be a mandatory part of medical education. We compared the quantity and quality of sex- and gender-related content of e-learning materials commonly used by German and American medical students ...
Ludwig, Sabine, Nauman, Ahmad T., Regitz-Zagrosek, Vera, Schluchter, Helena, Seeland, Ute   +4 more
core   +1 more source

Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

European Heart Journal
Background and Aims Long-term safety and efficacy of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) are unknown. MAVA-LTE (NCT03723655) is an ongoing, 5-year, open-label extension study designed to evaluate the long-term ...
Pablo García-Pavía, A. Oręziak, A. Masri, R. Barriales-Villa, T. Abraham, A. Owens, M. Jensen, Wojciech Wojakowski, Tim Seidler, A. Hagège, N. Lakdawala, Andrew Wang, M. Wheeler, L. Choudhury, G. Balaratnam, A. Shah, S. Fox, S. M. Hegde, I. Olivotto   +18 more
semanticscholar   +1 more source

Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
mid- ventricular, and post- SRT phenotypes. Patients with heart failure with preserved ejection fraction also represent a future target for CMIs given their mechanism of action.
Ahmad Masri, I. Olivotto
semanticscholar   +1 more source

Occurrence of Takotsubo Cardiomyopathy after Synthetic Cannabinoid Consumption [PDF]

Addiction and Health, 2019
Background: Synthetic cannabinoid use such as “K2” and “Spice” is popular secondary to its inability to be detected in a urine drug screen. It is associated with a wide range of myocardial pathologies including obstructive and non-obstructive coronary ...
Denelle Mohammed
doaj   +1 more source